Article
AbbVie takes $2.1 bln charge on cancer drug ahead of US price negotiation
Rating:
0.0
Views:
37
Likes:
1
Library:
1
AbbVie , girding for government price negotiations on its big-selling cancer drug Imbruvica, on Friday disclosed a $2.1 billion charge related to an expected drop in revenue once the new price for U.S. Medicare patients goes into effect.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value